Pharmaceutical Product Development

TrialMed, located in Austin, TX, is a prominent provider of global clinical research solutions, offering extensive expertise across more than 20 therapeutic areas. The company specializes in transforming drug development processes through innovative laboratory services and comprehensive project management, ensuring high-quality and timely delivery for its clients. With a commitment to advancing clinical research, TrialMed employs advanced technologies and strategic insights to streamline drug development, helping customers bring life-saving therapies to market more efficiently. Its dedication to collaboration and quality has earned recognition, positioning TrialMed as a leading partner for biotech and pharmaceutical companies seeking reliable and effective clinical trial solutions. Generated from the website

Tekton Research is a multi-state clinical research site network headquartered in Austin, TX, dedicated to conducting Phase 1-4 clinical trials across diverse therapeutic areas, including neurology, cardiometabolic, general medicine, and infectious disease. Founded in 2006, the organization boasts a team of seasoned clinical research professionals and renowned key opinion leaders, ensuring excellence in study start-up, recruitment, retention, and scientific rigor. The company collaborates with sponsors, CROs, and biopharma to accelerate the development of innovative therapies while prioritizing patient-centered care. With a network of experienced investigators and a commitment to quality, Tekton Research facilitates the advancement of medical discoveries and provides participants access to investigational therapies at no cost. Generated from the website

Elligo Health Research Inc, based in Austin, TX, specializes in enabling clinical trials by bridging the gap between research and healthcare. Through their proprietary Intelligo technology, they provide direct access to millions of diverse patients from various healthcare and research sites, supporting over 1,000 studies for more than 80 sponsors across 30 countries in 15 therapeutic areas. The company offers end-to-end support for sites, patient recruitment and engagement services, remote clinical research solutions, and technology to streamline trial placement. With a focus on enhancing traditional decentralized and hybrid trials, Elligo Health Research Inc is dedicated to reducing risk and increasing certainty in clinical trial management. Generated from the website